WHO ICTRP trial
Clinical efficacy analysis of Vonoprazan in the treatment of pharyngeal reflux…
ChiCTR2400090530 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400090530 |
|---|---|
| Public title | Clinical efficacy analysis of Vonoprazan in the treatment of pharyngeal reflux disease |
| Scientific title | Clinical efficacy analysis of Vonoprazan in the treatment of pharyngeal reflux disease |
| Primary sponsor | Yichang Central People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | laryngopharyngeal reflux disease |
| Interventions | Exposed group (Oral vonoprazan):none;non-exposed group (Oral rabeprazole):none |
| Registration date | Oct 8, 2024 |
| Target size | Exposed group (Oral vonoprazan):67;non-exposed group (Oral rabeprazole):133 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: